{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:08Z","timestamp":1786119008507,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/inf.0b013e318175d85c","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T08:37:12Z","timestamp":1222418232000},"page":"946-948","source":"Crossref","is-referenced-by-count":39,"title":["ACYCLOVIR-RESISTANT CHRONIC VERRUCOUS VACCINE STRAIN VARICELLA IN A PATIENT WITH NEUROBLASTOMA"],"prefix":"10.1097","volume":"27","author":[{"given":"Coleman J.","family":"Bryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Daily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroll","family":"Hartline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Cassady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hilliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210202","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1128\/AAC.49.3.1039-1045.2005","article-title":"In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.","volume":"49","author":"Kern","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R2-24-20210202","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.49.9.3724-3733.2005","article-title":"Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.","volume":"49","author":"Williams-Aziz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-24-20210202","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/AAC.01447-06","article-title":"Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.","volume":"51","author":"Prichard","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-24-20210202","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/378502","article-title":"Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"R5-24-20210202","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist Updat"},{"key":"R6-24-20210202","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1651-2227.2000.tb02785.x","article-title":"Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant.","volume":"89","author":"Crassard","year":"2000","journal-title":"Acta Paediatr"},{"key":"R7-24-20210202","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1001\/jama.1988.03410190127035","article-title":"Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.","volume":"260","author":"Pahwa","year":"1988","journal-title":"JAMA"},{"key":"R8-24-20210202","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1086\/324503","article-title":"Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome.","volume":"33","author":"Saint-L\u00e9ger","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-24-20210202","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2230.1999.00498.x","article-title":"Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects.","volume":"24","author":"Nikkels","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"R10-24-20210202","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/0264-410X(93)90164-S","article-title":"Susceptibility of Oka varicella vaccine strain to antiviral drugs.","volume":"11","author":"Shiraki","year":"1993","journal-title":"Vaccine"},{"key":"R11-24-20210202","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine.","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"issue":"RR-4","key":"R12-24-20210202","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R13-24-20210202","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00006454-199912000-00003","article-title":"Postmarketing evaluation of the safety and effectiveness of varicella vaccine.","volume":"18","author":"Black","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R14-24-20210202","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/320157","article-title":"A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.","volume":"32","author":"Offidani","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R15-24-20210202","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus.","volume":"342","author":"Gilden","year":"2000","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200810000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:50Z","timestamp":1786036310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200810000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318175d85c","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}